Q32 Bio Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
Q32 Bio Inc. (FIXX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price of $7.05 per share for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-13.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice · last filed 2024-03-13
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2023-03-31 was $7.19, a 41.59% decline year-over-year.
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2022-03-31 was $12.31, a 36.55% decline year-over-year.
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2021-03-31 was $19.40, a 0.87% decline year-over-year.
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2020-03-31 was $19.57, a 8.68% decline year-over-year.
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2023 was $7.05, a 31.22% decline from fiscal 2022.
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2022 was $10.25, a 41.43% decline from fiscal 2021.
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2021 was $17.50, a 23.08% decline from fiscal 2020.
- Q32 Bio Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2020 was $22.75, a 25.97% increase from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2023-12-31 | $7.05 10-K · filed 2024-03-13 | |||
| 2023-09-30 | $11.11 10-Q · filed 2023-11-14 | |||
| 2023-06-30 | $8.91 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | $7.19 10-Q · filed 2023-05-11 | |||
| 2022-12-31 | $10.25 10-K · filed 2023-03-09 | |||
| 2022-09-30 | $9.92 10-Q · filed 2022-11-10 | |||
| 2022-06-30 | $11.30 10-Q · filed 2022-08-15 | |||
| 2022-03-31 | $12.31 10-Q · filed 2022-05-16 | |||
| 2021-12-31 | $17.50 10-K · filed 2022-03-23 | |||
| 2021-09-30 | $17.59 10-Q · filed 2021-11-15 | |||
| 2021-06-30 | $18.62 10-Q · filed 2021-08-12 | |||
| 2021-03-31 | $19.40 10-Q · filed 2021-05-06 | |||
| 2020-12-31 | $22.75 10-K · filed 2021-03-11 | |||
| 2020-09-30 | $23.31 10-Q · filed 2020-11-09 | |||
| 2020-06-30 | $22.86 10-Q · filed 2020-08-10 | |||
| 2020-03-31 | $19.57 10-Q · filed 2020-05-07 | |||
| 2019-12-31 | $18.06 10-K · filed 2020-03-12 | |||
| 2019-09-30 | $18.17 10-Q · filed 2019-11-12 | |||
| 2019-06-30 | $18.16 10-Q · filed 2019-08-08 | |||
| 2019-03-31 | $21.43 10-Q · filed 2019-05-13 | |||
| 2018-12-31 | $2.72 10-K · filed 2019-03-12 | |||
| 2018-09-30 | $2.71 10-Q · filed 2018-11-13 | |||
| 2018-06-30 | $2.82 10-Q · filed 2018-08-13 | |||
| 2018-03-31 | $1.28 10-Q · filed 2018-05-14 |